Managing diagnostic procedures in idiopathic pulmonary fibrosis by Athol U. Wells

Get full text

New pharmacological strategies for the treatment of pulmonary fibrosis by Athena Gogali, Athol U. Wells

Get full text

Personalised medicine in interstitial lung diseases by Maria A. Kokosi, George A. Margaritopoulos, Athol U. Wells

Get full text

Imaging of Pulmonary Sarcoidosis—A Review by Georgina L. Bailey, Athol U. Wells, Sujal R. Desai

Get full text

Comorbidities in interstitial lung diseases by George A. Margaritopoulos, Katerina M. Antoniou, Athol U. Wells

Get full text

Sarcoidosis Associated Pulmonary Hypertension by Alexander Liu, Laura C. Price, Rakesh Sharma, Athol U. Wells, Vasileios Kouranos

Get full text

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation by Manuela Funke-Chambour, Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Athol U. Wells, Jacques Cadranel

Get full text

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges by Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells, Manuela Funke-Chambour

Get full text

Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do? by Sara Tomassetti, Thomas V. Colby, Athol U. Wells, Venerino Poletti, Ulrich Costabel, Marco Matucci-Cerinic

Get full text

The 6-min walk test as a primary end-point in interstitial lung disease by Sergio Harari, Athol U. Wells, Wim A. Wuyts, Steven D. Nathan, Klaus-Uwe Kirchgaessler, Monica Bengus, Jürgen Behr

Get full text

Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives by Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin, Athol U. Wells

Get full text

A combined pulmonary function and emphysema score prognostic index for staging in Chronic Obstructive Pulmonary Disease. by Afroditi K Boutou, Arjun Nair, Dariush Douraghi-Zadeh, Ranbir Sandhu, David M Hansell, Athol U Wells, Michael I Polkey, Nicholas S Hopkinson

Get full text

Pirfenidone improves survival in IPF: results from a real-life study by George A. Margaritopoulos, Athina Trachalaki, Athol U. Wells, Eirini Vasarmidi, Eleni Bibaki, George Papastratigakis, Stathis Detorakis, Nikos Tzanakis, Katerina M. Antoniou

Get full text

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? by Sergio Harari, Marc Humbert, Francesco Blasi, Harold R. Collard, Marco Matucci-Cerinic, Gerald Simonneau, Carlo Vancheri, Athol U. Wells, Vincent Cottin

Get full text

A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema by Athol U. Wells, Joseph Jacob, Nicola Sverzellati, Gary Cross, Joseph Barnett, Angelo De Lauretis, Katerina Antoniou, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin

Get full text

Idiopathic pulmonary fibrosis: prognostic impact of histologic honeycombing in transbronchial lung cryobiopsy by Claudia Ravaglia, Marcello Bosi, Athol U. Wells, Carlo Gurioli, Christian Gurioli, Alessandra Dubini, Sara Piciucchi, Silvia Puglisi, Susanna Mascetti, Antonella Arcadu, Sara Tomassetti, Venerino Poletti

Get full text

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients by Claudia Ravaglia, Athol U. Wells, Sara Tomassetti, Carlo Gurioli, Christian Gurioli, Alessandra Dubini, Alberto Cavazza, Thomas V. Colby, Sara Piciucchi, Silvia Puglisi, Marcello Bosi, Venerino Poletti

Get full text

Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis. by Kensaku Aihara, Tomohiro Handa, Toru Oga, Kizuku Watanabe, Kiminobu Tanizawa, Kohei Ikezoe, Yoshio Taguchi, Hiroe Sato, Kazuo Chin, Sonoko Nagai, Shuh Narumiya, Athol U Wells, Michiaki Mishima

Get full text

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases by Vincent Cottin, Nikhil A. Hirani, David L. Hotchkin, Anoop M. Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K. Poonyagariyagorn, Wim Wuyts, Athol U. Wells

Get full text

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial by Peter Saunders, Vicky Tsipouri, Gregory J. Keir, Deborah Ashby, Marcus D. Flather, Helen Parfrey, Daphne Babalis, Elisabetta A. Renzoni, Christopher P. Denton, Athol U. Wells, Toby M. Maher

Get full text